Connection Between Epigenome, Selective Mutability, Evolution, and Human Disease
Li, Harris et al., PLoS Genetics
Researchers at the Baylor College of Medicine and elsewhere propose a "connection between the epigenome, selective mutability, evolution, and human disease" based on the findings of their study on associations of structural mutability with germline DNA methylation and with non-allelic homologous recombination mediated by low-copy repeats. "Combined evidence from four human sperm methylome maps, human genome evolution, structural polymorphisms in the human population, and previous genomic and disease studies consistently points to a strong association of germline hypomethylation and genomic instability," the Baylor-led team writes.
Roche's Molecular Dx, Applied Science Revenues Rise in First-Half '09
July 23, 2009
Roche's MDx sales grew 5 percent in the first half of 2009, driven by its blood-screening portfolio and the recent launch of its TheraScreen K-RAS Mutation Test.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register quickly here for free access.
New to GenomeWeb? Register quickly here for free access.
Related Stories
- Genentech Takes Personalized Medicine Approach in Pursuing Amyloid Hypothesis for Alzheimer's Drug
May 23, 2012 / Pharmacogenomics Reporter - Ventana Sublicensing IP from Gen-Probe for ERG Protein Measurement
May 21, 2012 / GenomeWeb Daily News - GSK to Buy Cellzome for $99M as Pharma Interest in Chemical Proteomics Continues to Build
May 18, 2012 / ProteoMonitor - Molecular Screening Awareness Grows in Step with Adoption of Roche Melanoma Drug, Survey Finds
May 16, 2012 / Pharmacogenomics Reporter - Biodesix Presents Data Showing Veristrat Useful for Identifying Avastin-Tarceva Responders
April 27, 2012 / ProteoMonitor